GRObio

is a Massachusetts-based biotechnology company that researches and develops protein therapeutics for the treatment of autoimmune and metabolic diseases...
Read more
GRObio CEO: Daniel J. Mandell

CEO

Daniel J. Mandell

CEO Approval Rating

74/100

2016

PrivateIndependent Company

2836 NAICS listing
Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$87.4M

GRObio Competitors

1Lycia Therapeutics
2Kyverna
3Cabaletta Bio
4Acceleron
5bluebird bio
6ARIAD
7Sangamo
8Ambrx
9CRISPR
10Gradalis
See 15+ competitors

Trending Companies